Section 10400.7 - Krebiozen for Treatment of Cancer(a) As used in this section Krebiozen means that agent described and defined in the report entitled REPORT, FINDINGS AND RECOMMENDATIONS OF THE CANCER ADVISORY COUNCIL with respect to THE TREATMENT OF CANCER WITH KREBIOZEN dated May 27, 1964 and the supplementary report of said Council dated September 12, 1967.(b) Except as otherwise provided in Section 1708 of the Health and Safety Code, the prescription, administration, sale or other distribution of Krebiozen, as defined in subsection (a) of this section, or any substantially similar agent, drug, medicine, compound or device to any patient who has or who believes he or she has or who may have cancer is prohibited.(c) No person shall, for the purpose of prescribing, administering, selling or otherwise distributing Krebiozen, make any representation that said agent has any value in arresting, alleviating or curing cancer.Cal. Code Regs. Tit. 17, § 10400.7
1. New section filed 10-27-67; effective thirtieth day thereafter (Register 67, No. 43).
2. Amendment filed 12-17-85; effective thirtieth day thereafter (Register 85, No. 51). Note: Authority cited: Sections 208 and 1704, Health and Safety Code. Reference: Section 1704, Health and Safety Code.
1. New section filed 10-27-67; effective thirtieth day thereafter (Register 67, No. 43).
2. Amendment filed 12-17-85; effective thirtieth day thereafter (Register 85, No. 51).